Barclays Reaffirms Equal Weight Rating for uniQure (QURE)

uniQure N.V. (NASDAQ:QURE) is 1 of the 7 champion small-cap healthcare stocks to bargain according to hedge funds.

On March 23, Barclays expert Eliana Merle reduced the terms people connected uniQure N.V. (NASDAQ:QURE) from $31 to $25. The expert reaffirmed an Equal Weight standing connected the shares, which inactive connection a imaginable upside of much than 69% contempt the downward revision.

Romaset/Shutterstock.com

Although the exit of Vinay Prasad from the FDA could person a affirmative impact, determination are inactive risks associated with the company’s regulation. According to the analyst, a Phase 3 objective proceedings for Huntington’s illness volition beryllium required for the company.

On March 11, Mizuho accrued the firm’s terms people connected uniQure N.V. (NASDAQ:QURE) from $12 to $35. The steadfast upgraded the standing from Neutral to Outperform, which presently offers an upside imaginable of 137%.

Mizuho cited the caller departure of Dr. Vinay Prasad from the U.S. Food and Drug Administration, noting it could awesome a much flexible regulatory environment. It added that this displacement whitethorn reopen a way toward support based connected existing information oregon alternate proceedings designs, supporting a much constructive outlook connected the shares.

uniQure N.V. (NASDAQ:QURE) is focused connected processing therapeutics for patients suffering from uncommon and deadly diseases. Its merchandise portfolio includes HEMGENIX, AMT-260, AMT-162, and AMT- 130. It targets assorted aesculapian conditions specified arsenic hemophilia B, Huntington’s disease, mesial temporal lobe epilepsy, and more.

While we admit the imaginable of QURE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.